PMID- 8112866 OWN - NLM STAT- MEDLINE DCOM- 19940330 LR - 20210526 IS - 0019-9567 (Print) IS - 1098-5522 (Electronic) IS - 0019-9567 (Linking) VI - 62 IP - 3 DP - 1994 Mar TI - Recombinant expression and antigenic properties of a 32-kilodalton extracellular alkaline protease, representing a possible virulence factor from Aspergillus fumigatus. PG - 936-42 AB - A 32-kDa nonglycosylated alkaline protease (EC 3.4.1.14) with elastolytic activity, secreted by the opportunistic pathogen Aspergillus fumigatus ATCC 42202, is suggested to be a virulence factor of this fungus. The enzyme is a serine protease of the subtilisin family, and its cDNA nucleotide sequence has recently been reported. We have cloned the cDNA encoding the mature protease into a high-level Escherichia coli expression plasmid and produced the recombinant protease as a fusion protein with a six-adjacent-histidine affinity tag at the carboxy terminus. Subsequently, the recombinant protease was purified to homogeneity, with affinity chromatography yielding 30 to 40 mg of recombinant protease per liter of E. coli culture. Refolded recombinant protease, in comparison with native protease, demonstrated weak enzymatic activity but similar immunochemical characteristics as analyzed by antigen-specific enzyme-linked immunosorbent assay (ELISA), competition ELISA, and immunoblotting assays. To assess the allergenic potential of the protease, sera from patients with allergic bronchopulmonary aspergillosis and sera from healthy control individuals were analyzed by ELISA and immunoblotting techniques. Sera from patients with allergic bronchopulmonary aspergillosis did not have protease-specific immunoglobulin E (IgE) antibodies and, remarkably, did not show significantly elevated protease-specific IgG antibody levels compared with those in sera from healthy control individuals. This suggests that the alkaline protease from A. fumigatus does not elicit IgE antibodies and has weak immunogenicity, a property which may explain fungus persistence in allergic individuals. FAU - Moser, M AU - Moser M AD - Swiss Institute of Allergy and Asthma Research, Davos-Platz. FAU - Menz, G AU - Menz G FAU - Blaser, K AU - Blaser K FAU - Crameri, R AU - Crameri R LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - Infect Immun JT - Infection and immunity JID - 0246127 RN - 0 (Antigens, Bacterial) RN - 0 (Immunoglobulin G) RN - 0 (Recombinant Proteins) RN - EC 3.4.- (Endopeptidases) SB - IM MH - Amino Acid Sequence MH - Antigens, Bacterial/*immunology MH - Aspergillus fumigatus/*enzymology/immunology/pathogenicity MH - Base Sequence MH - Endopeptidases/analysis/*biosynthesis/immunology MH - Humans MH - Immunoglobulin G/analysis MH - Molecular Sequence Data MH - Molecular Weight MH - Protein Folding MH - Recombinant Proteins/*biosynthesis MH - Virulence PMC - PMC186206 EDAT- 1994/03/01 00:00 MHDA- 1994/03/01 00:01 PMCR- 1994/03/01 CRDT- 1994/03/01 00:00 PHST- 1994/03/01 00:00 [pubmed] PHST- 1994/03/01 00:01 [medline] PHST- 1994/03/01 00:00 [entrez] PHST- 1994/03/01 00:00 [pmc-release] AID - 10.1128/iai.62.3.936-942.1994 [doi] PST - ppublish SO - Infect Immun. 1994 Mar;62(3):936-42. doi: 10.1128/iai.62.3.936-942.1994.